Homrich & Berg’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $8.87M | Buy |
206,234
+2,835
| +1% | +$126K | 0.2% | 42 |
|
|
2021
Q2 | $7.96M | Buy |
203,399
+33,884
| +20% | +$1.32M | 0.19% | 42 |
|
|
2021
Q1 | $6.14M | Buy |
169,515
+11,970
| +8% | +$425K | 0.16% | 57 |
|
|
2020
Q4 | $5.8M | Sell |
157,545
-5,911
| -4% | -$217K | 0.16% | 53 |
|
|
2020
Q3 | $5.69M | Buy |
163,456
+11,675
| +8% | +$409K | 0.2% | 42 |
|
|
2020
Q2 | $4.71M | Buy |
151,781
+36,601
| +32% | +$1.24M | 0.19% | 40 |
|
|
2020
Q1 | $3.57M | Buy |
115,180
+4,737
| +4% | +$161K | 0.2% | 44 |
|
|
2019
Q4 | $4.11M | Buy |
110,443
+3,764
| +4% | +$134K | 0.19% | 43 |
|
|
2019
Q3 | $3.64M | Buy |
106,679
+175
| +0.2% | +$6.36K | 0.19% | 46 |
|
|
2019
Q2 | $4.38M | Buy |
106,504
+218
| +0.2% | +$8.66K | 0.23% | 36 |
|
|
2019
Q1 | $4.28M | Buy |
106,286
+4,700
| +5% | +$188K | 0.22% | 35 |
|
|
2018
Q4 | $4.21M | Sell |
101,586
-7,034
| -6% | -$292K | 0.25% | 31 |
|
|
2018
Q3 | $4.54M | Buy |
108,620
+7,712
| +8% | +$297K | 0.27% | 30 |
|
|
2018
Q2 | $3.47M | Sell |
100,908
-40,579
| -29% | -$1.39M | 0.25% | 34 |
|
|
2018
Q1 | $4.76M | Buy |
141,487
+15,450
| +12% | +$531K | 0.33% | 29 |
|
|
2017
Q4 | $4.33M | Sell |
126,037
-3,182
| -2% | -$109K | 0.3% | 31 |
|
|
2017
Q3 | $4.38M | Buy |
129,219
+42,120
| +48% | +$1.35M | 0.35% | 25 |
|
|
2017
Q2 | $2.78M | Buy |
87,099
+2,663
| +3% | +$84K | 0.24% | 32 |
|
|
2017
Q1 | $2.74M | Buy |
84,436
+3,749
| +5% | +$118K | 0.24% | 34 |
|
|
2016
Q4 | $2.49M | Sell |
80,687
-3,436
| -4% | -$105K | 0.22% | 37 |
|
|
2016
Q3 | $2.7M | Buy |
84,123
+2,305
| +3% | +$77.1K | 0.25% | 34 |
|
|
2016
Q2 | $2.73M | Sell |
81,818
-2,170
| -3% | -$69.3K | 0.26% | 31 |
|
|
2016
Q1 | $2.36M | Sell |
83,988
-567
| -0.7% | -$16.2K | 0.23% | 34 |
|
|
2015
Q4 | $2.59M | Sell |
84,555
-2,830
| -3% | -$89K | 0.24% | 38 |
|
|
2015
Q3 | $2.6M | Buy |
87,385
+2,387
| +3% | +$76.5K | 0.27% | 36 |
|
|
2015
Q2 | $2.7M | Sell |
84,998
-2,726
| -3% | -$88.8K | 0.26% | 36 |
|
|
2015
Q1 | $2.9M | Buy |
87,724
+2,292
| +3% | +$72.9K | 0.28% | 36 |
|
|
2014
Q4 | $2.52M | Sell |
85,432
-2,789
| -3% | -$80K | 0.26% | 40 |
|
|
2014
Q3 | $2.48M | Buy |
88,221
+11,194
| +15% | +$314K | 0.25% | 37 |
|
|
2014
Q2 | $2.17M | Buy |
77,027
+2,257
| +3% | +$64.3K | 0.25% | 33 |
|
|
2014
Q1 | $2.28M | Sell |
74,770
-3,381
| -4% | -$101K | 0.3% | 30 |
|
|
2013
Q4 | $2.27M | Buy |
78,151
+1,889
| +2% | +$55K | 0.32% | 27 |
|
|
2013
Q3 | $2.08M | Sell |
76,262
-4,438
| -5% | -$121K | 0.33% | 27 |
|
|
2013
Q2 | $2.15M | Buy |
+80,700
| New | +$2.23M | 0.39% | 24 |
|
Other funds holding PFE
Homrich & Berg's PFE Position: Q3 2021 in Review
Homrich & Berg increased its Pfizer (PFE) stake by 1.4% in Q3 2021, buying an estimated $126K and bringing the position to 206,234 shares worth $8.87M. The position accounts for 0.2% of the portfolio, ranked #42.
Homrich & Berg first reported a position in PFE in Q2 2013 and has held it in 34 quarters since. 2,803 funds tracked by Wall St. Rank hold PFE as of Q3 2021.
- Homrich & Berg held 206,234 shares of Pfizer worth $8.87M as of Q3 2021.
- Homrich & Berg bought 2,835 Pfizer shares in Q3 2021, an estimated $126K.
- Pfizer made up 0.2% of Homrich & Berg's portfolio in Q3 2021, its #42 holding.
- Homrich & Berg first reported a position in Pfizer in Q2 2013 and has held it in 34 quarters since.
- 2,803 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.
Based on Homrich & Berg's 13F filing for Q3 2021, filed 8 Dec 2021.